Afatinib Plus Bevacizumab Treatment for a Patient with EGFR S645C-Mutant Non-Small Cell Lung Cancer: A Case Report

Chia I. Shen, Ju Chen Chang, Suyog Jain, Steve Olsen, Chiao En Wu*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

Original languageEnglish
Article numbere2400007
Pages (from-to)e2400007
JournalJCO precision oncology
Volume8
DOIs
StatePublished - 01 06 2024

Keywords

  • Humans
  • Male
  • Afatinib/therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Bevacizumab/therapeutic use
  • Carcinoma, Non-Small-Cell Lung/drug therapy
  • ErbB Receptors/genetics
  • Lung Neoplasms/drug therapy
  • Mutation
  • Aged

Cite this